[Skip to Content]
[Skip to Content Landing]
Other Articles
September 26, 1936

Current Comment

JAMA. 1936;107(13):1056. doi:10.1001/jama.1936.02770390048017

SEYDEL ARTHRITIS TREATMENT —THE AFTERMATH  The tempest created by the premature publicity for the proprietary product promoted by Seydel through the American Chemical Society session in Pittsburgh has subsided, leaving behind it a calm atmosphere indicating that much good was accomplished by the protest which The Journal of the American Medical Association made against the publicity methods. The paper of Seydel was read in a closed meeting of the American Chemical Society. Dr. Paul Nicholas Leech, Director of the Bureau of Foods, Drugs and Physical Therapy of the American Medical Association, took part in the discussion. Following this discussion a statement was issued by Dr. Edward Bartow, president of the American Chemical Society, Dr. Thomas Midgley, chairman of the board of directors, and Dr. Norris Shreve, chairman of the division of medicinal chemistry, jointly with Dr. Leech. This statement said:In the discussion it was pointed out that much more

First Page Preview View Large
First page PDF preview
First page PDF preview